Tumor necrosis factor α is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy

Metabolism: Clinical and Experimental

Volumn 55, Issue 2, 2006, Pages 175-182

  Haugaard, Steen B ^a   Andersen, Ove ^a   Pedersen, Steen B ^b   Dela, Flemming ^c   Fenger, Mogens ^a   Richelsen, Bjørn ^b   Madsbad, Sten ^a   Iversen, Johan ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERINSULINEMIA; LIPID OXIDATION; LIPODYSTROPHY; MALE; PRIORITY JOURNAL; STEADY STATE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLYCEROL; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30744466427     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.08.018     Document Type: Article

References (38)

1. A. Carr, S. Emery, and M. Law An objective case definition of lipodystrophy in HIV-infected adults: a case-control study Lancet 361 2003 726 735
2. D. Chen, A. Misra, and A. Garg Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients J Clin Endocrinol Metab 87 2002 4845 4856
3. C. Hadigan, S. Borgonha, and J. Rabe Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy Metabolism 51 2002 1143 1147
4. D.N. Reeds, B. Mittendorfer, and B.W. Patterson Alterations in lipid kinetics in men with HIV-dyslipidemia Am J Physiol Endocrinol Metab 285 2003 E490 E497
5. R.V. Sekhar, F. Jahoor, and A.C. White Metabolic basis of HIV-lipodystrophy syndrome Am J Physiol Endocrinol Metab 283 2002 E332 E337
6. M. van der Valk, G. Allick, and G.J. Weverling Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients J Clin Endocrinol Metab 89 2004 3554 3560
7. A. Balasubramanyam, R.V. Sekhar, and F. Jahoor Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis' Curr Opin Lipidol 15 2004 59 67
8. G.S. Hotamisligil, P. Arner, and J.F. Caro Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J Clin Invest 95 1995 2409 2415
9. M. Ryden, A. Dicker, and V. van Harmelen Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells J Biol Chem 277 2002 1085 1091
10. H.H. Zhang, M. Halbleib, and F. Ahmad Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP Diabetes 51 2002 2929 2935
11. J.A. Johnson, J.B. Albu, and E.S. Engelson Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy Am J Physiol Endocrinol Metab 286 2004 E261 E271
12. C. Vigouroux, M. Maachi, and T.H. Nguyen Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy AIDS 17 2003 1503 1511
13. A.S. Lihn, B. Richelsen, and S.B. Pedersen Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels Am J Physiol Endocrinol Metab 285 2003 E1072 E1080
14. L.C. Groop, R.C. Bonadonna, and M. Shank Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man J Clin Invest 87 1991 83 89
15. K.R. Feingold, M. Soued, and S. Adi Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats Diabetes 39 1990 1569 1574
16. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
17. O. Andersen, S.B. Haugaard, and U.B. Andersen Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function Metabolism 52 2003 1343 1353
18. K.N. Frayn Calculation of substrate oxidation rates in vivo from gaseous exchange J Appl Physiol 55 1983 628 634
19. N. Fogh-Andersen, and P. D'Orazio Proposal for standardizing direct-reading biosensors for blood glucose Clin Chem 44 1998 655 659
20. S.B. Haugaard, O. Andersen, and H. Storgaard Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells Am J Physiol Endocrinol Metab 287 2004 E677 E685
21. S.B. Haugaard, O. Andersen, and F. Dela Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells Eur J Endocrinol 152 2005 103 112
22. P. Dandona, R. Weinstock, and K. Thusu Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J Clin Endocrinol Metab 83 1998 2907 2910
23. A. Katsuki, Y. Sumida, and S. Murashima Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 83 1998 859 862
24. C. Tsigos, I. Kyrou, and E. Chala Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity Metabolism 48 1999 1332 1335
25. S. Nielsen, Z. Guo, and C.M. Johnson Splanchnic lipolysis in human obesity J Clin Invest 113 2004 1582 1588
26. S.B. Haugaard, O. Andersen, and A. Volund Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy Clin Endocrinol (Oxf) 62 2005 354 361
27. R.V. Sekhar, F. Jahoor, and H.J. Pownall Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy Curr Atheroscler Rep 6 2004 173 179
28. C. Hadigan, J. Rabe, and G. Meininger Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution Am J Clin Nutr 77 2003 490 494
29. A. Rudich, S. Vanounou, and K. Riesenberg The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes Diabetes 50 2001 1425 1431
30. A. Rudich, R. Ben Romano, and S. Etzion Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors Acta Physiol Scand 183 2005 75 88
31. B. Maher, J. Lloyd, and E.G. Wilkins Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters Antivir Ther 9 2004 879 887
32. C.A. Mattacks, D. Sadler, and C.M. Pond Site-specific differences in the action of NRTI drugs on adipose tissue incubated in vitro with lymphoid cells, and their interaction with dietary lipids Comp Biochem Physiol C Toxicol Pharmacol 135 2003 11 29
33. C. Lagothu, J.P. Bastard, and M. Auclair Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro Antivir Ther 9 2004 911 920
34. P. Limone, A. Biglino, and M. Valle Insulin resistance in HIV-infected patients: relationship with pro-inflammatory cytokines released by peripheral leukocytes J Infect 47 2003 52 58
35. D. Nolan, and S. Mallal The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome J HIV Ther 9 2004 34 40
36. K.R. Feingold, and C. Grunfeld Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo J Clin Invest 80 1987 184 190
37. B. Lamarche, S. Rashid, and G.F. Lewis HDL metabolism in hypertriglyceridemic states: an overview Clin Chim Acta 286 1999 145 161
38. B. Lamarche, K.D. Uffelman, and A. Carpentier Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men J Clin Invest 103 1999 1191 1199